Your browser doesn't support javascript.
loading
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.
Goh, Jian Yuan; Feng, Min; Wang, Wenyu; Oguz, Gokce; Yatim, Siti Maryam J M; Lee, Puay Leng; Bao, Yi; Lim, Tse Hui; Wang, Panpan; Tam, Wai Leong; Kodahl, Annette R; Lyng, Maria B; Sarma, Suman; Lin, Selena Y; Lezhava, Alexander; Yap, Yoon Sim; Lim, Alvin S T; Hoon, Dave S B; Ditzel, Henrik J; Lee, Soo Chin; Tan, Ern Yu; Yu, Qiang.
Afiliación
  • Goh JY; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Feng M; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Wang W; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Oguz G; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Yatim SMJM; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Lee PL; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Bao Y; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Lim TH; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Wang P; Cytogenetics Laboratory, Department of Pathology, Singapore General Hospital, Singapore.
  • Tam WL; Cancer Research Institute and School of Pharmacy, Jinan University, Guangzhou, China.
  • Kodahl AR; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Lyng MB; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Sarma S; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Lin SY; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Lezhava A; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Yap YS; Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, California, USA.
  • Lim AST; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Hoon DSB; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Ditzel HJ; Cytogenetics Laboratory, Department of Pathology, Singapore General Hospital, Singapore.
  • Lee SC; Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, California, USA.
  • Tan EY; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Yu Q; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Nat Med ; 23(11): 1319-1330, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28967919
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 1 / Neoplasias de la Mama / Biomarcadores de Tumor / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 1 / Neoplasias de la Mama / Biomarcadores de Tumor / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Singapur